Available Technologies
# of Displayed Technologies: 1 / 1
miR-3151 and BAALC as a Target for Drug Therapy
TS-014895 — Identified gene target for treatment of human acute leukemia, brain tumors and melanoma
Treatment failure is one of the leading causes of death in patients with human acute leukemia, yet the cause of treatment failure is still largely unknown. Overexpression of the RNA gene miR-3151 and its host gene, Brain and Acute Leukemia, Cytplasmic (BAALC), is a sign of an ineffective treatment…
- College: College of Medicine (COM)
- Inventors: de la Chapelle, Albert; Eisfeld, Ann-Kathrin; Tanner, Stephan
- Licensing Officer: Schworer, Adam
